Non-alcoholic fatty liver disease (NAFLD) is strongly linked to elevated body mass index (BMI) and is characterized by increased levels of liver function markers such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST) [4,5]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.